Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)

To determine whether Xpert bladder cancer monitor, a noninvasive PCR-based biomarker test, can predict the need for 2nd transurethral resection of the bladder (TURB) better than clinical assessment. Patients scheduled for TURB were prospectively screened. After initial TURB, patients were assigned t...

Descripción completa

Detalles Bibliográficos
Autores principales: Breyer, Johannes, Eckstein, Markus, Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Haas, Maximilian, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Kriegmair, Maximilian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507065/
https://www.ncbi.nlm.nih.gov/pubmed/37723173
http://dx.doi.org/10.1038/s41598-023-42088-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507065/
https://www.ncbi.nlm.nih.gov/pubmed/37723173
http://dx.doi.org/10.1038/s41598-023-42088-z

Ejemplares similares